In a recent report, Dias and Couture [18] demonstrated that pharmacological blockade of the B1R protected rats against obesity and insulin resistance, and that these phenotypes were associated with decreased inflammation in retroperitoneal adipose tissue. Here, BDKRB1 is linked to obesity due to melanocortin 4 receptor deficiency.